OR WAIT null SECS
September 19, 2012
It is amazing what the human nose knows.
September 18, 2012
On July 9, 2012, the Generic Drug User Fee Act (GDUFA) was passed by the US Congress.
September 14, 2012
Earlier this week, on Sept. 12, 2012, the Pharmaceutical Research and Manufacturers of America (PhRMA) honored nine individuals for their research into and fight against Alzheimer’s Disease (AD) as part of the association’s new Research and Hope Awards
In the September PharmTech issue, researchers from MIT’s Center for Biomedical Innovation (CBI) describe the interim results from recent research into 34 commercial-scale biopharmaceutical products at 11 international sites.
The pharmaceutical industry still lags other industries in spending on outbound social media programs that engage customers directly.
September 13, 2012
In 2008, adverse affects and deaths linked to Baxter’s blood thinner drug heparin revealed contamination in the heparin supply chain originating from an API manufacturer in China. FDA identified oversulfated chondroitin sulfate (OSCS) in the contaminated heparin.
September 12, 2012
Researchers are trying to find better, cheaper ways to produce biodegradable and bio-based polymers.
September 11, 2012
Be sure to follow our Twitter feed from this year’s PDA-FDA Joint Regulatory Conference, taking place in Baltimore.
As the saying goes, an ounce of prevention is worth a pound of cure. The US Department of Health and Human Services (HHS) has taken that advice to heart.